Skip to content

Circum-Psoas Block for Arthroscopic Hip Surgery: A randomized, triple-blind,placebo controlled trial

Circum-Psoas Block for Arthroscopic Hip Surgery: A randomized, triple-blind,placebo controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082380
Enrollment
Unknown
Registered
2024-03-27
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Intervention:Ultrasound-guided circum-psoas block with 40 mL 0.2% Ropivacaine
Sham:Ultrasound-guided injection of 40ml normal saline in the same location as the circum-psoas block

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: • Primary unilateral ambulatory hip arthroscopy • Age 18 to 70 years • ASA physical status I to III • Ability to follow the protocol.

Exclusion criteria

Exclusion criteria: • Age 70 years of age • BMI above 40 • Contraindications to peripheral nerve blockade • Pregnancy • Chronic pain condition requiring opioid intake at home • Allergy to opioids or local anesthetics • Patient refusal

Design outcomes

Primary

MeasureTime frame
pain severity at 6 hours postoperatively;

Secondary

MeasureTime frame
pain severity at 1 hours ,12 hours and 24 hours postoperatively;Postoperative opioid consumption up to 24 hours postoperatively;Postoperative nausea and vomiting up to 24 hours postoperatively;neurologic evaluation at 1, 6, 24 hours postoperatively;Patient satisfaction at the end of 24 hours postoperatively;

Countries

China

Contacts

Public ContactNing Li

The Second Hospital of Shandong University

lining252252@126.com+86 137 9103 6442

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026